Guilei Ma
- Biomedical Engineering top 5%
- Biomaterials top 2%
- Immunology top 5%
- Molecular Biology
- Pharmaceutical Science top 2%
- Topics
- Nanoplatforms for cancer theranostics (14 papers)Immunotherapy and Immune Responses (12 papers)RNA Interference and Gene Delivery (10 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guilei Ma
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Biomedical Engineering 530
- Biomaterials 454
- Immunology 433
- Molecular Biology 361
- Pharmaceutical Science 135
Countries citing papers authored by Guilei Ma
This map shows the geographic impact of Guilei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilei Ma more than expected).
Fields of papers citing papers by Guilei Ma
This network shows the impact of papers produced by Guilei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilei Ma. The network helps show where Guilei Ma may publish in the future.
Co-authorship network of co-authors of Guilei Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Guilei Ma. A scholar is included among the top collaborators of Guilei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilei Ma. Guilei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 17 | |
| 4 | 3 | |
| 5 | 43 | |
| 6 | 89 | |
| 7 | 42 | |
| 8 | 32 | |
| 9 | 19 | |
| 10 | 87 | |
| 11 | 38 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 84 | |
| 15 | 6 | |
| 16 | 42 | |
| 17 | 16 | |
| 18 | 30 | |
| 19 | 48 | |
| 20 | 9 |
About Guilei Ma
Guilei Ma is a scholar working on Biomaterials, Immunology and Pharmaceutical Science, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Immunotherapy and Immune Responses (12 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Biomaterials (454 citations), Pharmaceutical Science (135 citations) and Immunology (433 citations). Guilei Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Cunxian Song, Hongfan Sun, Lanxia Liu, Yijia Liu, Mengmeng Yan, Deling Kong, Fengqiang Cao, Chun Wang, Xiaoli Wang and Xigang Leng. Their work appears in journals such as Biomaterials, Chemical Communications and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.